Investors Overview

Investors Overview

Our Mission

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

Learn more about BD

News Releases

04/14/2021

Summary Toggle BD Announces 510(k) Clearance of Pristine™ Long-Term Hemodialysis Catheter

Clearance supported by clinical data from a feasibility study with favorable primary patency rates observed out to 180 days FRANKLIN LAKES, N.J. , April 14, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced it has

PDF Version
04/13/2021

Summary Toggle BD MAX™ Molecular Multi-Drug Resistant Tuberculosis Test To Be Included In WHO Updated Consolidated Guidelines On Tuberculosis

WHO Rapid Communication cites high accuracy for the detection of TB, rifampicin and isoniazid resistance on respiratory samples FRANKLIN LAKES, N.J. , April 13, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that

PDF Version
04/05/2021

Summary Toggle BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021

FRANKLIN LAKES, N.J. , April 5, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX) announced today that it will report its financial results for the second quarter of fiscal year 2021 on Thursday, May 6, 2021 . BD will issue a press release detailing the quarter's results, along

PDF Version
04/01/2021

Summary Toggle BD to Invest $65 Million for Key Supply Chain Infrastructure in Tucson, Arizona to Increase Resiliency of U.S. Medical Device Supply

TUCSON, Ariz. , April 1, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the company's supply chain,

PDF Version
04/01/2021

Summary Toggle BD Receives Emergency Use Authorization for Asymptomatic Screening for SARS-CoV-2 through Serial Rapid Antigen Testing

BD Veritor™ Plus System supports return-to-school and return-to-work programs through serial testing FRANKLIN LAKES, N.J. , April 1, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced the U.S.

PDF Version
03/30/2021

Summary Toggle BD Announces FDA Emergency Use Authorization for Combination COVID-19, Flu Rapid Antigen Test

New Test on the BD Veritor™ Plus System Can Detect SARS-CoV-2, Influenza A, Influenza B from Single Patient Sample FRANKLIN LAKES, N.J. , March 30, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced the U.S.

PDF Version